Meet Kathy 

​​​

Kathy Perez brings over 30 years of leadership across BioPharma’s commercial, R&D, and patient advocacy landscapes. Most recently, as VP and Head of Global Patient Advocacy at argenx, she led strategy across 15 rare autoimmune indications—translating patient insights into high-impact business outcomes.

​

Under Kathy’s leadership, biotechnology companies have launched groundbreaking Public/Private stakeholder collaborations and unique award winning podcast programs . But these efforts were never just about awareness—they were built to advance patient conversations, inform physician decision-making, and support more inclusive care models.

 

Kathy now brings this model to biopharma clients—bridging advocacy and business with a unique combination of:

• Compliance Fluency – deep knowledge of regulatory safeguards in working with patient organizations and protecting ethical boundaries.

• Commercial Strategy – the ability to position advocacy within core business drivers: access, uptake, and market differentiation.

• Execution Rigor – a track record of delivering real programs that meet objectives, align internal teams, and drive measurable outcomes.

 

“Advocacy isn’t a feel-good function—it’s a strategic lever. When it’s built right, it drives smarter science and stronger stakeholder trust.”